B+
Bull case
20%
Probability
Target price
$21.00
+23.5% vs current
Coverage is thin and targets cluster in the high‑teens. Consensus implies modest upside from the anchor and a cautious market stance; positioning is income-driven with limited conviction around growth catalysts.
No evidence quality warning is currently attached to this memo.
Quarterly results and same-store NOI / occupancy commentary could reprice the stock; exact release date not disclosed, modeled at quarter-end [#SERP-3].
Next dividend announcement could shift income-seeking flows and affect yield premium; market consensus implies modest upside expectations [#SERP-2].
Refinancing costs and major lease rollovers over 12 months could materially compress NAV and AFFO; structural for healthcare REITs [#SERP-6].
No formal recommendation provided.